Dr. Ajay Bhargava, MD

Dr. Bhargava practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Bhargava's NPI, 1134232721, was assigned on August 16, 2006. Dr. Bhargava holds Ohio license 35086358.

Dr. Bhargava's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Bhargava's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Bhargava is also affiliated with Fairview Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Bhargava to 3 more hospitals, 2 clinical labs and 1 medical group, each named with a free account. Dr. Bhargava's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhargava practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bhargava's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bhargava is licensed in Ohio.

CMS data shows 5,337 Medicare services from Dr. Bhargava across 16 procedure codes in 2024, for 3,661 Medicare patients. Medicare paid $87,072 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 3,661 Medicare patients who saw Dr. Bhargava in 2024. The largest group is 65 to 74, with 1,741 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhargava's median patient age at 66, with 42% women.

In 2024, Dr. Bhargava wrote 843 Medicare Part D claims for 150 patients. 84% of them were for generic drugs. CMS names the drug for 731 of them, across 19 drugs with 11 or more claims each, at $148,852 in total drug cost. In 2023, CMS named 813 claims across 21 drugs.

Dr. Bhargava accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhargava as offering telehealth.

Dmand AI links 23 papers to Dr. Bhargava, published from 2012 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Cell Line, Tumor, Cell Line and Disease Models, Animal. Dr. Bhargava has published most often in Elife. Dr. Bhargava's most frequent co-authors are Edward Paul Amento, MD, Swati Arora and Arpit Bhargava, MD.

CMS Open Payments shows 3 general payments to Dr. Bhargava from 3 drug and device companies in 2016. Food and beverage make up the largest share, 100% of the total. Medivance, Inc. paid the most, $43.